Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF2R | P11717 | 3/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.39 |
| ▸ | SELL | P14151 | 3/20 | 0.39 |
| ▸ | SELP | P16109 | 3/20 | 0.39 |
| ▸ | SELE | P16581 | 3/20 | 0.39 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALPI | P09923 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALPG | P10696 | 1/20 | 0.38 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | GALK1 | P51570 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | CASP6 | P55212 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17918994 | 0.84 | FOLH1 (0.43) | IGF2RLGALS3SELLSELPSELE | |
| SCHEMBL699573 | 0.79 | IGF2R (0.40) | IGF2RLGALS3SELLSELPSELE | |
| SCHEMBL28444663 | 0.78 | CA12 (0.44) | GAAFOLH1 | |
| SCHEMBL734876 | 0.78 | CA12 (0.44) | GAAFOLH1 | |
| SCHEMBL28448246 | 0.78 | CA12 (0.44) | GAAFOLH1 | |
| SCHEMBL28448523 | 0.78 | CA12 (0.44) | GAAFOLH1 | |
| Cellobiose SCHEMBL8673451 | 0.78 | IGF2R (0.47) | IGF2RLGALS3LMNA | |
| SCHEMBL9346601 | 0.76 | CA12 (0.42) | GAAFOLH1 | |
| SCHEMBL4756847 | 0.72 | SELP (0.34) | IGF2RLGALS3SELPGAAFOLH1 | |
| SCHEMBL28869638 | 0.72 | SYNJ2 (0.40) | IGF2RSYNJ2KDM4EABL1ALPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260074073-A1 | Biomarker for Seronegative Rheumatoid Arthritis | MAYO FOUND MEDICAL EDUCATION & RES (US) | 2026-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260074073-A1 | Biomarker for Seronegative Rheumatoid Arthritis | SSB, HLA-DRB1, SERPINA6 | IGF2R 3280/4885LGALS3 19/4885SELL 204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.